EP1420808A4 - Treatment of tuberculosis using immunomodulator compounds - Google Patents
Treatment of tuberculosis using immunomodulator compoundsInfo
- Publication number
- EP1420808A4 EP1420808A4 EP01271057A EP01271057A EP1420808A4 EP 1420808 A4 EP1420808 A4 EP 1420808A4 EP 01271057 A EP01271057 A EP 01271057A EP 01271057 A EP01271057 A EP 01271057A EP 1420808 A4 EP1420808 A4 EP 1420808A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- tuberculosis
- treatment
- immunomodulator compounds
- immunomodulator
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09000806A EP2078525A3 (en) | 2001-06-08 | 2001-12-20 | Treatment of tuberculosis using immunomodulator compounds |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2001115900/14A RU2229892C2 (en) | 2001-06-08 | 2001-06-08 | Method for treatment of pulmonary tuberculosis |
RU2001115900 | 2001-08-06 | ||
PCT/US2001/048560 WO2003013572A1 (en) | 2001-06-08 | 2001-12-20 | Treatment of tuberculosis using immunomodulator compounds |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP09000806A Division EP2078525A3 (en) | 2001-06-08 | 2001-12-20 | Treatment of tuberculosis using immunomodulator compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1420808A1 EP1420808A1 (en) | 2004-05-26 |
EP1420808A4 true EP1420808A4 (en) | 2006-06-07 |
Family
ID=20250617
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP01271057A Withdrawn EP1420808A4 (en) | 2001-06-08 | 2001-12-20 | Treatment of tuberculosis using immunomodulator compounds |
EP09000806A Withdrawn EP2078525A3 (en) | 2001-06-08 | 2001-12-20 | Treatment of tuberculosis using immunomodulator compounds |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP09000806A Withdrawn EP2078525A3 (en) | 2001-06-08 | 2001-12-20 | Treatment of tuberculosis using immunomodulator compounds |
Country Status (4)
Country | Link |
---|---|
EP (2) | EP1420808A4 (en) |
JP (1) | JP4837251B2 (en) |
RU (1) | RU2229892C2 (en) |
WO (1) | WO2003013572A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ551457A (en) * | 2004-05-14 | 2009-12-24 | Sciclone Pharmaceuticals Inc | Treatment or prevention of respiratory viral infections with immunomodulator compounds |
US20090074815A1 (en) * | 2005-04-22 | 2009-03-19 | Sciclone Pharmaceuticals, Inc. | Immunomodulator Compounds as Vaccine Enhancers |
CA2677749A1 (en) | 2007-02-13 | 2008-08-21 | Sciclone Pharmaceuticals, Inc. | Method of treating or preventing tissue deterioration, injury or damage due to disease of mucosa |
JP2010536854A (en) * | 2007-08-23 | 2010-12-02 | サイクローン・ファーマシューティカルズ・インコーポレイテッド | Lung cancer treatment |
RU2450820C2 (en) * | 2010-07-20 | 2012-05-20 | Государственное учреждение "Научно-практический центр "Фтизиатрия" Министерства здравоохранения республики Саха (Якутия) | Method of treating destructive pulmonary tuberculosis |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994020063A2 (en) * | 1993-03-04 | 1994-09-15 | Cytoven International N.V. | Pharmaceutical tryptophan containing dipeptide compositions and methods of use thereof |
WO1997019691A1 (en) * | 1995-11-28 | 1997-06-05 | Wei, Edward, T. | Gamma-l-glutamyl containing immunomodulator compounds and methods therewith |
US5916878A (en) * | 1995-11-28 | 1999-06-29 | Edward T. Wei | γ-glutamyl and β-aspartyl containing immunomodulator compounds and methods therewith |
US6060452A (en) * | 1996-03-13 | 2000-05-09 | Cytran, Inc. | Analogs of L-Glu-L-Trp having pharmacological activity |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4520196A (en) * | 1983-08-18 | 1985-05-28 | American Home Products Corporation | α-Mercaptophenylacetic acid derivatives of imidazole-containing compounds and analogues thereof |
US5212192A (en) * | 1989-11-24 | 1993-05-18 | Janssen Pharmaceutica N.V. | Immunostimulating 6-aryl-5,6-dihydroimidazo[2,1-b]thiazole derivatives |
ES2174124T3 (en) * | 1995-12-14 | 2002-11-01 | Novelos Therapeutics Inc | GLUTATION OXIDIZED AS AN INCREASER OF THE ENDOGENOUS PRODUCTION OF CYTOKINES AND HEMATOPOYETIC FACTORS. |
-
2001
- 2001-06-08 RU RU2001115900/14A patent/RU2229892C2/en not_active IP Right Cessation
- 2001-12-20 WO PCT/US2001/048560 patent/WO2003013572A1/en active Application Filing
- 2001-12-20 JP JP2003518578A patent/JP4837251B2/en not_active Expired - Fee Related
- 2001-12-20 EP EP01271057A patent/EP1420808A4/en not_active Withdrawn
- 2001-12-20 EP EP09000806A patent/EP2078525A3/en not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994020063A2 (en) * | 1993-03-04 | 1994-09-15 | Cytoven International N.V. | Pharmaceutical tryptophan containing dipeptide compositions and methods of use thereof |
WO1997019691A1 (en) * | 1995-11-28 | 1997-06-05 | Wei, Edward, T. | Gamma-l-glutamyl containing immunomodulator compounds and methods therewith |
US5916878A (en) * | 1995-11-28 | 1999-06-29 | Edward T. Wei | γ-glutamyl and β-aspartyl containing immunomodulator compounds and methods therewith |
US6060452A (en) * | 1996-03-13 | 2000-05-09 | Cytran, Inc. | Analogs of L-Glu-L-Trp having pharmacological activity |
Non-Patent Citations (8)
Title |
---|
BIOCENTURY, 8(10, PT. 2), P. B13. ISSN: 1097-7201; CODEN: BICEFS., 28 February 2000 (2000-02-28) * |
BUCHAN G.S. ET AL: "Tuberculosis in domesticated deer cervus-elaphus a large anumal model for tuberculosis", JOURNAL OF COMPARATIVE PATHOLOGY, vol. 103, no. 1, 1990, pages 11 - 22 * |
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1990, Database accession no. PREV199090100455 * |
DATABASE CIN [online] "Other Research News", XP002377620, retrieved from STN Database accession no. 29(11):11078F * |
DATABASE IMSDRUGNEWS [online] R & D Focus Drug News; 22 January 2001 (2001-01-22), XP002377621, retrieved from STN Database accession no. AN = 2001:333 * |
DATABASE IMSDRUGNEWS [online] R & D Focus Drug News; 6 September 1999 (1999-09-06), XP002377619, retrieved from STN Database accession no. 1999:2565 * |
NICOLAUS B.J.R.: "symbiotic approach to drug design", DECISION MAKING IN DRUG RESEARCH, 1983, pages 173 - 186, XP002197412 * |
See also references of WO03013572A1 * |
Also Published As
Publication number | Publication date |
---|---|
RU2229892C2 (en) | 2004-06-10 |
EP1420808A1 (en) | 2004-05-26 |
JP2004537579A (en) | 2004-12-16 |
EP2078525A3 (en) | 2010-09-08 |
WO2003013572A1 (en) | 2003-02-20 |
EP2078525A2 (en) | 2009-07-15 |
JP4837251B2 (en) | 2011-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2393202B (en) | Methods of well treatment | |
IL156595A0 (en) | Therapeutic heterocyclic compounds | |
GB0121155D0 (en) | Treatment of substrates | |
GB0109087D0 (en) | Treatment of suspensions | |
GB0211295D0 (en) | Treatment of pain | |
GB0124124D0 (en) | Methods of treatment | |
EP1389105A4 (en) | Method of treatment | |
IL161748A0 (en) | New use for the treatment of gastroesophageal reflux | |
EP1420808A4 (en) | Treatment of tuberculosis using immunomodulator compounds | |
GB0112216D0 (en) | Method of treatment | |
GB0118892D0 (en) | Method of treatment | |
GB2380481B (en) | Means for treatment of atherosclerosis | |
AU2002255448A1 (en) | Treatment of tuberculosis using immunomodulator compounds | |
GB0100092D0 (en) | Treatment of degenerative diseases | |
EP1451308A4 (en) | Therapeutic use of aziridino compounds | |
AU2002341485A1 (en) | Treatment of polyaluminium compounds | |
GB0120654D0 (en) | Treatment of anemia | |
GB0118023D0 (en) | Treatment of ischemia | |
AU2003276123A8 (en) | Treatment of uveal melanoma | |
GB0229986D0 (en) | Treatment of materials | |
HU0104370D0 (en) | Honeyed schnaps of oerseg | |
GB0104886D0 (en) | Treatment of dandruff | |
GB0104615D0 (en) | Treatment of technetium | |
GB0105097D0 (en) | Treatment of technetium | |
GB0120406D0 (en) | Treatment of anemia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20040227 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1064952 Country of ref document: HK |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20060504 |
|
17Q | First examination report despatched |
Effective date: 20061123 |
|
17Q | First examination report despatched |
Effective date: 20061123 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Effective date: 20090122 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1064952 Country of ref document: HK |